Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
0.9300
+0.0001 (0.01%)
Oct 19, 2026, 11:49 AM EDT - Market open
Pluri Employees
As of June 30, 2026, Pluri had 113 total employees, including 92 full-time and 21 part-time employees. The number of employees decreased by 29 or -20.42% compared to the previous year. That makes Pluri the 30,669th largest employer in the world and 3,920th in the United States.
Employees
113
Change (1Y)
-29
Growth (1Y)
-20.42%
Revenue / Employee
$8,991
Profits / Employee
-$210,805
Market Cap
11.48M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 113 | -29 | -20.42% | 92 | 21 |
| Jun 30, 2025 | 142 | 24 | 20.34% | 127 | 15 |
| Jun 30, 2024 | 118 | -16 | -11.94% | 106 | 12 |
| Jun 30, 2023 | 134 | -25 | -15.72% | 123 | 11 |
| Jun 30, 2022 | 159 | -3 | -1.85% | 154 | 5 |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Passage Bio | 24 |
| BioLineRx | 24 |
| Citius Pharmaceuticals | 23 |
| IN8bio | 18 |
| Radiopharm Theranostics | 14 |
| Cellectar Biosciences | 11 |
| AEON Biopharma | 8 |
PLUR News
- 6 days ago - Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity - GlobeNewsWire
- 12 days ago - Pluri registers to sell 2.29M common shares for holders - TheFly
- 5 weeks ago - Pluri files $200M mixed securities shelf - TheFly
- 7 weeks ago - Pluri prices 2.23M shares at $1.50 in registered direct offering - TheFly
- 7 weeks ago - Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor - GlobeNewsWire
- 2 months ago - Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - GlobeNewsWire
- 2 months ago - Pluri Advances Commercial Expansion Through Its Subsidiary Cellav, Completing Regulatory Registration in the UK - GlobeNewsWire
- 3 months ago - Pluri announces chairman Alejandro Weinstein ownership surpasses 30% - TheFly